{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:38:52Z","timestamp":1792636732262,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Accumulating evidence indicates that gut microbiota plays a role in the progression of Parkinson\u2019s disease (PD). Microbiota-based treatments for prodromal PD, which is accompanied by a wide range of neuropsychiatric symptoms, are being considered a potential early intervention but are still under-investigated. This study examined the association between symptoms of affective and motivational impairments and gut dysbiosis in a transgenic mouse model (line G2-3) that overexpresses A53T mutant \u03b1-synuclein, a key protein involved in the disease pathology. By introducing biologically meaningful variations, such as genotype-based social grouping, efforts have been made to strengthen validity of the results and their translational relevance. Behavioral assessment was conducted on 6-month-old mice (the premotor stage) using Open Field, Elevated Plus Maze, Sucrose Preference and Tail Suspension tests. Fecal microbiota of mice was analyzed using 16S rRNA gene sequencing. Obtained data revealed a strong behavioral phenotype in transgenic mice expressed as co-occurrence of consummatory anhedonia and sensation-seeking\/risk-taking behavior, without significant motivational deficits and with variable gut dysbiosis: mixed-genotype housing, among others, prominently favored Bacteroidaceae\/\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    , as observed in PD patients, while single-genotype housing increased\n                    <jats:italic>Dubosiella<\/jats:italic>\n                    , a key bacteria in gut-originated PD model, along with the enrichment of\n                    <jats:italic>Bifidobacterium pseudolongum<\/jats:italic>\n                    , a well-known health-promoting bacterium. Overall, using a mouse model with adequate construct validity, this study identifies challenges in novel strategies that consider gut microbiota as an early diagnostic and therapeutic target for PD; it highlights the potential of the examined transgenic strain in studying low hedonic tone- and sensation-seeking-associated PD prodrome, building the basis for personalized medicine.\n                  <\/jats:p>","DOI":"10.1038\/s41398-026-04306-w","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:22:51Z","timestamp":1785144171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexistence of anhedonia and sensation-seeking with context-dependent gut dysbiosis in a prodromal transgenic mouse model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Olga","family":"Dubljevi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161anka","family":"Popovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Potrebi\u0107 Stefanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7817-4092","authenticated-orcid":false,"given":"Branka","family":"Petkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilija","family":"Brdari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-4398","authenticated-orcid":false,"given":"Franziska","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1415-5834","authenticated-orcid":false,"given":"Vesna","family":"Pe\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"4306_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","volume":"21","author":"D Weintraub","year":"2022","unstructured":"Weintraub D, Aarsland D, Chaudhuri KR, Dobkin RD, Leentjens AF, Rodriguez-Violante M, et al. The neuropsychiatry of Parkinson\u2019s disease: advances and challenges. Lancet Neurol. 2022;21:89\u2013102.","journal-title":"Lancet Neurol"},{"key":"4306_CR2","doi-asserted-by":"crossref","unstructured":"Heim B, Djamshidian A. Neuropsychiatric disorders in Parkinson\u2019s disease. Ther Adv Neurol Disord. 2025;18:17562864251356062.","DOI":"10.1177\/17562864251356062"},{"key":"4306_CR3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397:2284\u2013303.","journal-title":"Lancet"},{"key":"4306_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"K Seppi","year":"2019","unstructured":"Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, et al. Update on treatments for nonmotor symptoms of Parkinson\u2019s disease-an evidence-based medicine review. Mov Disord. 2019;34:180\u201398.","journal-title":"Mov Disord"},{"key":"4306_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. NPJ Parkinsons Dis. 2021;7:27.","journal-title":"NPJ Parkinsons Dis"},{"key":"4306_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen ZD, Demirkan A, Twa G, Cohen G, Dean MN, Standaert DG, et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun. 2022;13:6958.","journal-title":"Nat Commun"},{"key":"4306_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00415-025-13138-5","volume":"272","author":"PJ Oliver","year":"2025","unstructured":"Oliver PJ, Civitelli L, Hu MT. The gut-brain axis in early Parkinson\u2019s disease: from prodrome to prevention. J Neurol. 2025;272:413.","journal-title":"J Neurol"},{"key":"4306_CR8","doi-asserted-by":"publisher","first-page":"S369","DOI":"10.3233\/JPD-230393","volume":"14","author":"H Yamakado","year":"2024","unstructured":"Yamakado H, Takahashi R. Experimental animal models of prodromal Parkinson\u2019s disease. J Parkinsons Dis. 2024;14:S369\u2013S379.","journal-title":"J Parkinsons Dis"},{"key":"4306_CR9","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, Stirling W, Xu Y, Xu X, Qui D, Mandir AS, et al. Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 \u2013> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA. 2002;99:8968\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4306_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40035-019-0146-z","volume":"8","author":"L Rota","year":"2019","unstructured":"Rota L, Pellegrini C, Benvenuti L, Antonioli L, Fornai M, Blandizzi C, et al. Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy. Transl Neurodegener. 2019;8:5.","journal-title":"Transl Neurodegener"},{"key":"4306_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13578-023-01049-9","volume":"13","author":"XY Liu","year":"2023","unstructured":"Liu XY, Wang K, Deng XH, Wei YH, Guo R, Liu SF, et al. Amelioration of olfactory dysfunction in a mouse model of Parkinson\u2019s disease via enhancing GABAergic signaling. Cell Biosci. 2023;13:101.","journal-title":"Cell Biosci"},{"key":"4306_CR12","doi-asserted-by":"publisher","first-page":"111273","DOI":"10.1016\/j.pnpbp.2025.111273","volume":"137","author":"O Dubljevi\u0107","year":"2025","unstructured":"Dubljevi\u0107 O, Pavkovi\u0107 \u017d, Srbovan M, Potrebi\u0107 M, Stanojlovi\u0107 M, Pe\u0161i\u0107 V. Attention-deficit\/hyperactivity disorder-related psychomotor activity and altered neuronal activity in the medial prefrontal cortex and striatum in the A53T mouse model of Parkinson\u2019s disease and other synucleinopathies: Findings from an \u201cendophenotype\u201d approach. Prog Neuropsychopharmacol Biol Psychiatry. 2025;137:111273.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4306_CR13","doi-asserted-by":"publisher","first-page":"119462","DOI":"10.1016\/j.jad.2025.119462","volume":"386","author":"Z Radomyslsky","year":"2025","unstructured":"Radomyslsky Z, Kivity S, Cohen R, Saban M. ADHD and Parkinson\u2019s disease: unraveling the link and implications for early intervention. J Affect Disord. 2025;386:119462.","journal-title":"J Affect Disord"},{"key":"4306_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.17","volume":"6","author":"R Magnard","year":"2016","unstructured":"Magnard R, Vachez Y, Carcenac C, Krack P, David O, Savasta M, et al. What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson\u2019s disease?. Transl Psychiatry. 2016;6:e753.","journal-title":"Transl Psychiatry"},{"key":"4306_CR15","doi-asserted-by":"publisher","first-page":"1597559","DOI":"10.3389\/fpsyt.2025.1597559","volume":"16","author":"X Fu","year":"2025","unstructured":"Fu X, Wu W, Wu Y, Liu X, Liang W, Wu R. Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. Front Psychiatry. 2025;16:1597559.","journal-title":"Front Psychiatry"},{"key":"4306_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jad.2020.01.137","volume":"266","author":"BL Mason","year":"2020","unstructured":"Mason BL, Li Q, Minhajuddin A, Czysz AH, Coughlin LA, Hussain SK, et al. Reduced anti-inflammatory gut microbiota are associated with depression and anhedonia. J Affect Disord. 2020;266:394\u2013401.","journal-title":"J Affect Disord"},{"key":"4306_CR17","doi-asserted-by":"publisher","first-page":"810860","DOI":"10.3389\/fnagi.2022.810860","volume":"14","author":"Z Mari","year":"2022","unstructured":"Mari Z, Mestre TA. The disease modification conundrum in parkinson\u2019s disease: failures and hopes. Front Aging Neurosci. 2022;14:810860.","journal-title":"Front Aging Neurosci"},{"key":"4306_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1678-1","volume":"16","author":"P Pound","year":"2018","unstructured":"Pound P, Ritskes-Hoitinga M. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail. J Transl Med. 2018;16:304.","journal-title":"J Transl Med"},{"key":"4306_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0023677220968583","volume":"55","author":"M Eggel","year":"2021","unstructured":"Eggel M, W\u00fcrbel H. Internal consistency and compatibility of the 3Rs and 3Vs principles for project evaluation of animal research. Lab Anim. 2021;55:233\u201343.","journal-title":"Lab Anim"},{"key":"4306_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev-psych-062520-122331","volume":"72","author":"DB O\u2019Connor","year":"2021","unstructured":"O\u2019Connor DB, Thayer JF, Vedhara K. Stress and health: A review of psychobiological processes. Annu Rev Psychol. 2021;72:663\u201388.","journal-title":"Annu Rev Psychol"},{"key":"4306_CR21","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/01.ATV.20.6.1425","volume":"20","author":"CD Sigmund","year":"2000","unstructured":"Sigmund CD. Viewpoint: are studies in genetically altered mice out of control?. Arterioscler Thromb Vasc Biol. 2000;20:1425\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4306_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/eji.201142048","volume":"42","author":"R Holmdahl","year":"2012","unstructured":"Holmdahl R, Malissen B. The need for littermate controls. Eur J Immunol. 2012;42:45\u201347.","journal-title":"Eur J Immunol"},{"key":"4306_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.physbeh.2015.04.023","volume":"146","author":"M Yang","year":"2015","unstructured":"Yang M, Lewis F, Foley G, Crawley JN. In tribute to Bob Blanchard: Divergent behavioral phenotypes of 16p11.2 deletion mice reared in same-genotype versus mixed-genotype cages. Physiol Behav. 2015;146:16\u201327.","journal-title":"Physiol Behav"},{"key":"4306_CR24","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.3390\/biomedicines13061506","volume":"13","author":"O Dubljevi\u0107","year":"2025","unstructured":"Dubljevi\u0107 O, Dragoj M, Potrebi\u0107 Stefanovi\u0107 M, Srbovan M, Stanojlovi\u0107 M, Pavkovi\u0107 \u017d. Genotype-based housing as a potential confounder in studies using transgenic mouse models-insight from the A53T mouse model of Parkinson\u2019s disease. Biomedicines. 2025;13:1506.","journal-title":"Biomedicines"},{"key":"4306_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2045-5380-1-9","volume":"1","author":"C Belzung","year":"2011","unstructured":"Belzung C, Lemoine M. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol Mood Anxiety Disord. 2011;1:9.","journal-title":"Biol Mood Anxiety Disord"},{"key":"4306_CR26","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mdc3.70029","volume":"12","author":"E Menozzi","year":"2025","unstructured":"Menozzi E, Schapira AHV, Borghammer P. The gut-brain axis in Parkinson disease: emerging concepts and therapeutic implications. Mov Disord Clin Pract. 2025;12:904\u201316.","journal-title":"Mov Disord Clin Pract"},{"key":"4306_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg D, Borghammer P, Fereshtehnejad SM, Heinzel S, Horsager J, Schaeffer E, et al. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nat Rev Neurol. 2021;17:349\u201361.","journal-title":"Nat Rev Neurol"},{"key":"4306_CR28","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3233\/JPD-213070","volume":"12","author":"B Meira","year":"2022","unstructured":"Meira B, Lhomm\u00e9e E, Schmitt E, Klinger H, Bichon A, P\u00e9lissier P, et al. Early Parkinson\u2019s disease phenotypes tailored by personality, behavior, and motor symptoms. J Parkinsons Dis. 2022;12:1665\u201376.","journal-title":"J Parkinsons Dis"},{"key":"4306_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/femsre\/fuv036","volume":"40","author":"D Laukens","year":"2016","unstructured":"Laukens D, Brinkman BM, Raes J, De Vos M, Vandenabeele P. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol Rev. 2016;40:117\u201332.","journal-title":"FEMS Microbiol Rev"},{"key":"4306_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","volume":"21","author":"EL Unger","year":"2006","unstructured":"Unger EL, Eve DJ, Perez XA, Reichenbach DK, Xu Y, Lee MK, et al. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. Neurobiol Dis. 2006;21:431\u201343.","journal-title":"Neurobiol Dis"},{"key":"4306_CR31","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/jnr.22331","volume":"88","author":"DR Graham","year":"2010","unstructured":"Graham DR, Sidhu A. Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior. J Neurosci Res. 2010;88:1777\u201383.","journal-title":"J Neurosci Res"},{"key":"4306_CR32","first-page":"136","volume":"34","author":"F Dellu","year":"1996","unstructured":"Dellu F, Piazza PV, Mayo W, Le Moal M, Simon H. Novelty-seeking in rats\u2013biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology. 1996;34:136\u201345.","journal-title":"Neuropsychobiology"},{"key":"4306_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01194-6","volume":"11","author":"R Mejias","year":"2021","unstructured":"Mejias R, Rodriguez-Gotor JJ, Niwa M, Krasnova IN, Adamczyk A, Han M, et al. Increased novelty-induced locomotion, sensitivity to amphetamine, and extracellular dopamine in striatum of Zdhhc15-deficient mice. Transl Psychiatry. 2021;11:65.","journal-title":"Transl Psychiatry"},{"key":"4306_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0091-3057(93)90492-C","volume":"44","author":"D Treit","year":"1993","unstructured":"Treit D, Menard J, Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav. 1993;44:463\u20139.","journal-title":"Pharmacol Biochem Behav"},{"key":"4306_CR35","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2:322\u20138.","journal-title":"Nat Protoc"},{"key":"4306_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnbeh.2013.00103","volume":"7","author":"Y-C Yen","year":"2013","unstructured":"Yen Y-C, Anderzhanova E, Bunck M, Schuller J, Landgraf R, Wotjak CT. Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety. Front Behav Neurosci. 2013;7:103.","journal-title":"Front Behav Neurosci"},{"key":"4306_CR37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0092-6566(03)00067-9","volume":"38","author":"JW Roberti","year":"2004","unstructured":"Roberti JW. A review of behavioral and biological correlates of sensation seeking. J Res Pers. 2004;38:256\u201379.","journal-title":"J Res Pers"},{"key":"4306_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tins.2011.11.005","volume":"35","author":"A Der-Avakian","year":"2012","unstructured":"Der-Avakian A, Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci. 2012;35:68\u201377.","journal-title":"Trends Neurosci"},{"key":"4306_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ynstr.2016.08.001","volume":"6","author":"P Willner","year":"2016","unstructured":"Willner P. Reliability of the chronic mild stress model of depression: A user survey. Neurobiol Stress. 2016;6:68\u201377.","journal-title":"Neurobiol Stress"},{"key":"4306_CR40","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.1007\/s12035-018-0931-1","volume":"55","author":"C Yamada","year":"2018","unstructured":"Yamada C, Mogami S, Kanno H, Hattori T. Peptide YY causes apathy-like behavior via the dopamine D2 receptor in repeated water-immersed mice. Mol Neurobiol. 2018;55:7555\u201366.","journal-title":"Mol Neurobiol"},{"key":"4306_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1196\/annals.1417.003","volume":"1129","author":"RD Palmiter","year":"2008","unstructured":"Palmiter RD. Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice. Ann N Y Acad Sci. 2008;1129:35\u201346.","journal-title":"Ann N Y Acad Sci"},{"key":"4306_CR42","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00726-011-0924-0","volume":"42","author":"J Wei","year":"2012","unstructured":"Wei J, Carroll RJ, Harden KK, Wu G. Comparisons of treatment means when factors do not interact in two-factorial studies. Amino Acids. 2012;42:2031\u20135.","journal-title":"Amino Acids"},{"key":"4306_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0149-7634(99)00058-5","volume":"24","author":"T Sagvolden","year":"2000","unstructured":"Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit\/hyperactivity disorder (AD\/HD). Neurosci Biobehav Rev. 2000;24:31\u201339.","journal-title":"Neurosci Biobehav Rev"},{"key":"4306_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12402-010-0034-y","volume":"3","author":"B Langen","year":"2011","unstructured":"Langen B, Dost R. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists. Atten Defic Hyperact Disord. 2011;3:1\u201312.","journal-title":"Atten Defic Hyperact Disord"},{"key":"4306_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","volume":"52","author":"RJ Rodgers","year":"1995","unstructured":"Rodgers RJ, Johnson NJ. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav. 1995;52:297\u2013303.","journal-title":"Pharmacol Biochem Behav"},{"key":"4306_CR46","first-page":"1","volume":"15","author":"JL Rico","year":"2016","unstructured":"Rico JL, Hurtado-Parrado C, V\u00e1squez-Sep\u00falveda J, Fonseca J, Cardona A. Time spent in the central area of the elevated plus-maze correlates with impulsivity-related measures during a temporally-defined schedule of reinforcement. Universitas Psychologica. 2016;15:1\u20139.","journal-title":"Universitas Psychologica"},{"key":"4306_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","volume":"108","author":"A Bari","year":"2013","unstructured":"Bari A, Robbins TW. Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol. 2013;108:44\u201379.","journal-title":"Prog Neurobiol"},{"key":"4306_CR48","doi-asserted-by":"publisher","DOI":"10.1037\/11555-000","volume-title":"Sensation Seeking and Risky Behaviour","author":"M Zuckerman","year":"2007","unstructured":"Zuckerman M Sensation Seeking and Risky Behaviour. Washington, DC: American Psychiatric Association; 2007."},{"key":"4306_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1037\/1528-3542.5.4.396","volume":"5","author":"S Lissek","year":"2005","unstructured":"Lissek S, Baas JM, Pine DS, Orme K, Dvir S, Rosenberger E, et al. Sensation seeking and the aversive motivational system. Emotion. 2005;5:396\u2013407.","journal-title":"Emotion"},{"key":"4306_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.37708\/psyct.v14i1.551","volume":"14","author":"S Stoyanova","year":"2021","unstructured":"Stoyanova S, Ivantchev N. Associations among functional and dysfunctional impulsivity: direct and indirect effects on sensation seeking in youth (19-25 years old). Psychol Thought. 2021;14:115\u201349.","journal-title":"Psychol Thought"},{"key":"4306_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00005053-199305000-00006","volume":"181","author":"WF McCourt","year":"1993","unstructured":"McCourt WF, Gurrera RJ, Cutter HS. Sensation seeking and novelty seeking. Are they the same?. J Nerv Ment Dis. 1993;181:309\u201312.","journal-title":"J Nerv Ment Dis"},{"key":"4306_CR52","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders-DSM 5","author":"American Psychiatric Association (APA","year":"2013","unstructured":"American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders-DSM 5. Washington, DC: American Psychiatric publishing; 2013. p. 947. Fifth ed."},{"key":"4306_CR53","first-page":"278","volume":"21","author":"MT Treadway","year":"2023","unstructured":"Treadway MT. Treating motivational and consummatory aspects of anhedonia. Focus (Am Psychiatr Publ). 2023;21:278\u201380.","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"4306_CR54","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1037\/amp0000059","volume":"71","author":"KC Berridge","year":"2016","unstructured":"Berridge KC, Robinson TE. Liking, wanting, and the incentive-sensitization theory of addiction. Am Psychol. 2016;71:670\u20139.","journal-title":"Am Psychol"},{"key":"4306_CR55","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2147\/NDT.S111818","volume":"12","author":"T Sternat","year":"2016","unstructured":"Sternat T, Katzman MA. Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse. Neuropsychiatr Dis Treat. 2016;12:2149\u201364.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4306_CR56","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s42761-023-00193-2","volume":"4","author":"D Becker","year":"2023","unstructured":"Becker D, Bernecker K. The role of hedonic goal pursuit in self-control and self-regulation: is pleasure the problem or part of the solution?. Affect Sci. 2023;4:470\u20134.","journal-title":"Affect Sci"},{"key":"4306_CR57","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.expneurol.2007.12.017","volume":"210","author":"S George","year":"2008","unstructured":"George S, van den Buuse M, San Mok S, Masters CL, Li QX, Culvenor JG. Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour. Exp Neurol. 2008;210:788\u201392.","journal-title":"Exp Neurol"},{"key":"4306_CR58","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3233\/JPD-223165","volume":"12","author":"N Radisavljevic","year":"2022","unstructured":"Radisavljevic N, Cirstea M, Bauer K, Lo C, Metcalfe-Roach A, Bozorgmehr T, et al. Effects of gut microbiota alterations on motor, gastrointestinal, and behavioral phenotype in a mouse model of Parkinson\u2019s disease. J Parkinsons Dis. 2022;12:1479\u201395.","journal-title":"J Parkinsons Dis"},{"key":"4306_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fpsyt.2016.00091","volume":"7","author":"JL Houeto","year":"2016","unstructured":"Houeto JL, Magnard R, Dalley JW, Belin D, Carnicella S. Trait impulsivity and anhedonia: two gateways for the development of impulse control disorders in Parkinson\u2019s disease?. Front Psychiatry. 2016;7:91 https:\/\/doi.org\/10.3389\/fpsyt.2016.00091.","journal-title":"Front Psychiatry"},{"key":"4306_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-82139-7","volume":"15","author":"TR Sampson","year":"2025","unstructured":"Sampson TR, Wallen ZD, Won WJ, Standaert DG, Payami H, Harms AS. Alpha synuclein overexpression can drive microbiome dysbiosis in mice. Sci Rep. 2025;15:4014. https:\/\/doi.org\/10.1038\/s41598-024-82139-7.","journal-title":"Sci Rep"},{"key":"4306_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-019-0100-x","volume":"5","author":"S Weis","year":"2019","unstructured":"Weis S, Schwiertz A, Unger MM, Becker A, Fa\u00dfbender K, Ratering S, et al. Effect of Parkinson\u2019s disease and related medications on the composition of the fecal bacterial microbiota. NPJ Parkinsons Dis. 2019;5:28 https:\/\/doi.org\/10.1038\/s41531-019-0100-x.","journal-title":"NPJ Parkinsons Dis"},{"key":"4306_CR62","doi-asserted-by":"crossref","unstructured":"Plassais J, Gbikpi-Benissan G, Figarol M, Scheperjans F, Gorochov G, Derkinderen P, et al. Gut microbiome alpha-diversity is not a marker of Parkinson\u2019s disease and multiple sclerosis. Brain Commun. 2021;3:fcab113.","DOI":"10.1093\/braincomms\/fcab113"},{"key":"4306_CR63","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ame2.12257","volume":"5","author":"J Guo","year":"2022","unstructured":"Guo J, Song C, Liu Y, Wu X, Dong W, Zhu H, et al. Characteristics of gut microbiota in representative mice strains: Implications for biological research. Animal Model Exp Med. 2022;5:337\u201349.","journal-title":"Animal Model Exp Med"},{"key":"4306_CR64","doi-asserted-by":"publisher","first-page":"796025","DOI":"10.3389\/fmicb.2021.796025","volume":"12","author":"JG Kers","year":"2022","unstructured":"Kers JG, Saccenti E. The power of microbiome studies: some considerations on which alpha and beta metrics to use and how to report results. Front Microbiol. 2022;12:796025.","journal-title":"Front Microbiol"},{"key":"4306_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ame2.12134","volume":"3","author":"I Cahana","year":"2020","unstructured":"Cahana I, Iraqi FA. Impact of host genetics on gut microbiome: Take-home lessons from human and mouse studies. Animal Model Exp Med. 2020;3:229\u201336.","journal-title":"Animal Model Exp Med"},{"key":"4306_CR66","doi-asserted-by":"publisher","first-page":"e00826","DOI":"10.1128\/AEM.00826-19","volume":"85","author":"H Korach-Rechtman","year":"2019","unstructured":"Korach-Rechtman H, Freilich S, Gerassy-Vainberg S, Buhnik-Rosenblau K, Danin-Poleg Y, Bar H, et al. Murine genetic background has a stronger impact on the composition of the gut microbiota than maternal inoculation or exposure to unlike exogenous microbiota. Appl Environ Microbiol. 2019;85:e00826\u201319.","journal-title":"Appl Environ Microbiol"},{"key":"4306_CR67","doi-asserted-by":"publisher","first-page":"e0183509","DOI":"10.1371\/journal.pone.0183509","volume":"12","author":"E Aarts","year":"2017","unstructured":"Aarts E, Ederveen THA, Naaijen J, Zwiers MP, Boekhorst J, Timmerman HM, et al. Gut microbiome in ADHD and its relation to neural reward anticipation. PLoS One. 2017;12:e0183509.","journal-title":"PLoS One"},{"key":"4306_CR68","doi-asserted-by":"publisher","first-page":"1174800","DOI":"10.3389\/fmicb.2023.1174800","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Wang J, Wang M, Zheng L, Cen Q, Wang F, et al. Bifidobacterium: a probiotic for the prevention and treatment of depression. Front Microbiol. 2023;14:1174800.","journal-title":"Front Microbiol"},{"key":"4306_CR69","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1099\/ijsem.0.004107","volume":"70","author":"J Zheng","year":"2020","unstructured":"Zheng J, Wittouck S, Salvetti E, Franz CMAP, Harris HMB, Mattarelli P, et al. A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol. 2020;70:2782\u2013858.","journal-title":"Int J Syst Evol Microbiol"},{"key":"4306_CR70","doi-asserted-by":"publisher","first-page":"101943","DOI":"10.1016\/j.cpr.2020.101943","volume":"83","author":"CA Simpson","year":"2021","unstructured":"Simpson CA, Diaz-Arteche C, Eliby D, Schwartz OS, Simmons JG, Cowan CSM. The gut microbiota in anxiety and depression - A systematic review. Clin Psychol Rev. 2021;83:101943.","journal-title":"Clin Psychol Rev"},{"key":"4306_CR71","doi-asserted-by":"publisher","first-page":"112444","DOI":"10.1016\/j.exger.2024.112444","volume":"191","author":"F Bai","year":"2024","unstructured":"Bai F, You L, Lei H, Li X. Association between increased and decreased gut microbiota abundance and Parkinson\u2019s disease: A systematic review and subgroup meta-analysis. Exp Gerontol. 2024;191:112444.","journal-title":"Exp Gerontol"},{"key":"4306_CR72","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41390-022-02027-6","volume":"92","author":"D Gkougka","year":"2022","unstructured":"Gkougka D, Mitropoulos K, Tzanakaki G, Panagouli E, Psaltopoulou T, Thomaidis L, et al. Gut microbiome and attention deficit\/hyperactivity disorder: a systematic review. Pediatr Res. 2022;92:1507\u201319.","journal-title":"Pediatr Res"},{"key":"4306_CR73","doi-asserted-by":"publisher","first-page":"2417179","DOI":"10.1080\/07853890.2024.2417179","volume":"56","author":"Q Zhong","year":"2024","unstructured":"Zhong Q, Wu W, Xie J, Wang JL, Xu K, Ren Y, et al. Limosilactobacillus-related 3-OMDP as a potential therapeutic target for depression. Ann Med. 2024;56:2417179.","journal-title":"Ann Med"},{"key":"4306_CR74","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuroscience.2025.01.031","volume":"569","author":"N Lewis","year":"2025","unstructured":"Lewis N, Villani A, Lagopoulos J. Gut dysbiosis as a driver of neuroinflammation in attention-deficit\/hyperactivity disorder: A review of current evidence. Neuroscience. 2025;569:298\u2013321.","journal-title":"Neuroscience"},{"key":"4306_CR75","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbi.2025.04.001","volume":"128","author":"J Wu","year":"2025","unstructured":"Wu J, Li CS, Huang WY, Zhou SY, Zhao LP, Li T, et al. Gut microbiota promote the propagation of pathologic \u03b1-syn from gut to brain in a gut-originated mouse model of Parkinson\u2019s disease. Brain Behav Immun. 2025;128:152\u201369.","journal-title":"Brain Behav Immun"},{"key":"4306_CR76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pbb.2018.12.001","volume":"176","author":"N Huang","year":"2019","unstructured":"Huang N, Hua D, Zhan G, Li S, Zhu B, Jiang R, et al. Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression. Pharmacol Biochem Behav. 2019;176:93\u2013100.","journal-title":"Pharmacol Biochem Behav"},{"key":"4306_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0379-8","volume":"9","author":"C Yang","year":"2019","unstructured":"Yang C, Fang X, Zhan G, Huang N, Li S, Bi J, et al. Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain. Transl Psychiatry. 2019;9:57.","journal-title":"Transl Psychiatry"},{"key":"4306_CR78","doi-asserted-by":"publisher","first-page":"e166655","DOI":"10.1172\/jci.insight.166655","volume":"8","author":"Z Li","year":"2023","unstructured":"Li Z, Zhou E, Liu C, Wicks H, Yildiz S, Razack F, et al. Dietary butyrate ameliorates metabolic health associated with selective proliferation of gut Lachnospiraceae bacterium 28-4. JCI Insight. 2023;8:e166655.","journal-title":"JCI Insight"},{"key":"4306_CR79","doi-asserted-by":"publisher","first-page":"818","DOI":"10.18632\/oncotarget.28779","volume":"16","author":"H Do","year":"2025","unstructured":"Do H, Asiamah E, Olorife M, Pillai A, Patel S, Selvakumar P, et al. Mechanism of anticancer action of bifidobacterium: Insights from gut microbiota. Oncotarget. 2025;16:818\u201333.","journal-title":"Oncotarget"},{"key":"4306_CR80","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/gutjnl-2024-333020","volume":"74","author":"K Nan","year":"2025","unstructured":"Nan K, Zhong Z, Yue Y, Shen Y, Zhang H, Wang Z, et al. Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8+ T cells. Gut. 2025;74:775\u201386.","journal-title":"Gut"},{"key":"4306_CR81","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1177\/1877718X251380261","volume":"15","author":"S Khan","year":"2025","unstructured":"Khan S, Gupta A, Agarwal A, Alam MA, Kanagala SG, Jain R. Beyond the brain: The colorectal impact of Parkinson\u2019s disease. J Parkinsons Dis. 2025;15:1337\u201344.","journal-title":"J Parkinsons Dis"},{"key":"4306_CR82","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/ijms22020795","volume":"22","author":"M Stanojlovic","year":"2021","unstructured":"Stanojlovic M, Pallais JP, Kotz CM. Inhibition of orexin\/hypocretin neurons ameliorates elevated physical activity and energy expenditure in the A53T mouse model of Parkinson\u2019s disease. Int J Mol Sci. 2021;22:795.","journal-title":"Int J Mol Sci"},{"key":"4306_CR83","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3390\/nu12051474","volume":"12","author":"F Magne","year":"2020","unstructured":"Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, et al. The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?. Nutrients. 2020;12:1474.","journal-title":"Nutrients"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04306-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04306-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:02:20Z","timestamp":1792634540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04306-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4306"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04306-w","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"580"}}